Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice (Q74091486)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

R S Clements

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

W G Robison

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M P Cohen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

Journal of Diabetes and its Complications

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

28-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Clinical utility of nonenzymatically glycosylated blood proteins as an index of glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albumin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Prevention of decline in renal function in the diabetic db/db mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Early immunopathologic events in experimental diabetic nephropathy: a study in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic Microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Binding sites for short-term glycated albumin on peritoneal cells of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Production and characterization of monoclonal antibodies against human glycoalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Ocular pathology of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900051-2

7 January 2021

10.1016/S1056-8727(97)00051-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442812%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference